Načítá se...
Myeloid‐derived suppressor cells—a new therapeutic target to overcome resistance to cancer immunotherapy
Myeloid‐derived suppressor cells (MDSCs) are a heterogeneous population of immature myeloid cells that accumulate during pathologic conditions, such as cancer. Patients diagnosed with advanced metastatic cancers have an average survival of 12–24 mo, a survival time that hasn't changed significa...
Uloženo v:
| Vydáno v: | J Leukoc Biol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Society for Leukocyte Biology
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6608049/ https://ncbi.nlm.nih.gov/pubmed/28546500 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1189/jlb.5VMR1116-458RRR |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|